Polio Clinical Trial - Immunogenicity & Safety Evaluation of Different

See also
Status	Clinical Trial	Phase
Completed	`NCT00772369` - Retrospective Survey of Safety of Fourth Dose Pentacel® in Children	Phase 4
Completed	`NCT00401531` - Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants	Phase 3
Completed	`NCT00254917` - Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines	Phase 4
Completed	`NCT00772928` - Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™	Phase 3
Completed	`NCT04576910` - Immunogenicity and Safety of the Booster Dose of Polio Vaccine With Different Primary Sequential Schedules in China	Phase 4
Completed	`NCT04264546` - Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib)	Phase 1/Phase 2
Not yet recruiting	`NCT06114810` - Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), bOPV and IPV	Phase 4
Completed	`NCT01475539` - Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine	Phase 4
Completed	`NCT01244464` - A Study of the Safety of IMOVAX Polio™ in China	Phase 4
Completed	`NCT00255047` - Safety and Immune Response of Different Pediatric Combination Vaccines.	Phase 3
Recruiting	`NCT05850364` - A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine	Phase 3
Completed	`NCT00662870` - Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine	Phase 3
Completed	`NCT05083039` - Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19
Active, not recruiting	`NCT00932269` - Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease	Phase 0
Completed	`NCT03922061` - Evaluation of Safety, Reactogenicity and Immunogenicity of Fractional-dose Inactivated Polio Vaccine (fIPV) Given Intradermally With Double Mutant Enterotoxigenic Escherichia Coli Heat Labile Toxin (dmLT) Adjuvant	Phase 1
Enrolling by invitation	`NCT03818477` - Environmental Surveillance (ES) for Polio and AMR Using the TaqMan Array Card
Completed	`NCT00348387` - Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV	Phase 3
Not yet recruiting	`NCT06460545` - Phase IV Study of Concomitant Administration of the sIPV and HepA	Phase 4
Active, not recruiting	`NCT01908114` - To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in Pakistan	Phase 4
Completed	`NCT01389687` - Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan	Phase 3

NCT number	NCT03147560
Study type	Interventional
Source	Zhejiang Provincial Center for Disease Control and Prevention
Contact
Status	Completed
Phase	Phase 4
Start date	May 2, 2017
Completion date	December 30, 2017

Immunogenicity and Safety Evaluation of Different Sequential Immunization Strategies by Sabin IPV and bOPV in Chinese Infants

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms